EZEKIEL EMANUEL

Ezekiel Emanuel is a distinguished Venture Partner at Oak HC/FT, a premier venture and growth equity firm specializing in healthcare and financial technology. In this pivotal role, Dr. Emanuel brings his profound understanding of healthcare systems, policy, and ethics to inform and shape the firm's investment decisions within the dynamic healthcare sector. His unique perspective is invaluable in identifying companies poised for significant impact and growth.

At Oak HC/FT, Ezekiel Emanuel's investment focus areas are deeply rooted in his career-long dedication to improving health outcomes and healthcare delivery. He is particularly interested in digital health solutions, healthcare services innovation, health technology platforms, and companies that address critical policy challenges or leverage policy changes for market advantage. His expertise helps the firm evaluate the potential of new technologies and business models to navigate complex regulatory environments and achieve widespread adoption. He advises on strategic direction, market trends, and the ethical implications of emerging healthcare innovations, ensuring that investments align with long-term societal benefit and sustainable growth.

Dr. Emanuel's illustrious career background provides a robust foundation for his contributions to venture capital. He is widely recognized as a leading bioethicist and a prominent voice in health policy. Currently, he serves as the Vice Provost for Global Initiatives and the Diane v.S. Levy and Robert M. Levy University Professor at the University of Pennsylvania. Prior to his academic roles, he held significant positions within the U.S. government, notably as a special advisor for health policy to the Director of the Office of Management and Budget in the Obama administration. He was also the founding chair of the Department of Bioethics at the National Institutes of Health, where he conducted groundbreaking research on end-of-life care, medical ethics, and healthcare reform. His extensive experience across academia, government, and clinical practice offers an unparalleled lens through which to assess healthcare investment opportunities.

While specific individual investments by a Venture Partner are often part of a broader firm strategy, Ezekiel Emanuel contributes significantly to the strategic direction of Oak HC/FT's healthcare portfolio. His guidance helps the firm back companies that are not only financially promising but also offer meaningful advancements in patient care, operational efficiency, and health equity. His involvement ensures that Oak HC/FT remains at the forefront of healthcare innovation, supporting ventures that are truly poised to reshape the future of health.